Medscape

Atrial Fibrillation in Chronic Aortic Regurgitation Linked to Increased Mortality Risk

Atrial fibrillation (AF) was present in 1 in 6 patients with chronic aortic regurgitation — either moderate-to-severe or severe — and was independently associated with an increased risk for mortality ...
MedPage Today

First TAVR System Approved for Severe Aortic Regurgitation

The FDA approved the Trilogy Transcatheter Heart Valve System for the treatment of symptomatic severe aortic regurgitation, device maker JenaValve Technology announced. This approval makes Trilogy the ...
TCTMD

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

NEW YORK, NY—For patients with pure native aortic regurgitation (AR) who are undergoing TAVI, use of devices tailored to treat the AR seems to provide superior outcomes compared with off-label use of ...
Medscape

First TAVR for Aortic Regurgitation Moves to Phase 3 Trial

WASHINGTON — A phase 3 randomized trial will soon begin for the first transcatheter aortic valve replacement (TAVR) device for the treatment of aortic valve regurgitation after promising results in a ...
FierceBiotech

JenaValve's Trilogy valve secures FDA's 1st approval in aortic regurgitation

JenaValve has secured the FDA’s approval for its minimally invasive heart implant, making it the first to claim a U.S. green light to treat severe backflow through the aortic valve. And it gets to ...
TCTMD

SAVR Bests TAVI in Patients With Highly Calcific Aortic Valves

COPENHAGEN, Denmark—Among patients with severe aortic stenosis at low- or intermediate-risk for surgery who also have very calcified aortic valves, SAVR is associated with lower risks of all-cause ...
Healio

TAVR to treat symptomatic aortic regurgitation feasible

Please provide your email address to receive an email when new articles are posted on . A transcatheter aortic valve replacement system designed to treat aortic regurgitation exceeded its safety and ...